{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:09:37Z","timestamp":1791155377829,"version":"4.1.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T00:00:00Z","timestamp":1200873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1750-9378-3-1","type":"journal-article","created":{"date-parts":[[2008,1,22]],"date-time":"2008-01-22T07:14:08Z","timestamp":1200986048000},"source":"Crossref","is-referenced-by-count":40,"title":["Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma"],"prefix":"10.1186","volume":"3","author":[{"given":"Liviu","family":"Feller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Lemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,21]]},"reference":[{"key":"33_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1590\/S0041-87812002000400008","volume":"57","author":"JC Leao","year":"2002","unstructured":"Leao JC, Caterino-de-Araujo A, Porter SR, Scully C: Human herpesvirus 8 (HHV-8) and the etiopathogenesis of Kaposi's sarcoma. Rev Hosp Clin Fac Med Sao Paulo. 2002, 57: 175-186.","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"key":"33_CR2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0190-9622(93)70057-Z","volume":"28","author":"JW Tappero","year":"1993","unstructured":"Tappero JW, Conant MA, Wolfe SF, Berger TG: Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol. 1993, 28: 371-395.","journal-title":"J Am Acad Dermatol"},{"key":"33_CR3","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.4049\/jimmunol.174.6.3686","volume":"174","author":"KK Jensen","year":"2005","unstructured":"Jensen KK, Manfra DJ, Grisotto MG, Martin AP, Vassileva G, Kelly K: The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma. J Immunol. 2005, 174: 3686-3694.","journal-title":"J Immunol"},{"key":"33_CR4","first-page":"291","volume":"4","author":"L Feller","year":"2004","unstructured":"Feller L, Jadwat Y, Raubenheimer EJ: Kaposi sarcoma and calcium channel blocker-induced gingival enlargement occurring simultaneously: Review of the literature and report of a case. Oral Biosci Med. 2004, 4: 291-297.","journal-title":"Oral Biosci Med"},{"key":"33_CR5","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1200\/JCO.2005.04.156","volume":"23","author":"JH Gallafent","year":"2005","unstructured":"Gallafent JH, Buskin SE, De Turk PB, Aboulafia DM: Profile of patients with Kaposi's Sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol. 2005, 23: 1253-1260. 10.1200\/JCO.2005.04.156.","journal-title":"J Clin Oncol"},{"key":"33_CR6","first-page":"1076","volume-title":"Harrison's Principles of Internal Medicine","author":"AS Fauci","year":"2005","unstructured":"Fauci AS, Lane HC: Human immunodeficiency virus disease: Aids and related disorders. Harrison's Principles of Internal Medicine. Edited by: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL. 2005, New York: McGraw-Hill, 1076-1139. 16","edition":"16"},{"key":"33_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1473-3099(02)00263-3","volume":"2","author":"UR Hengge","year":"2002","unstructured":"Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA: Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical manifestations and therapy. Lancet Infect Dis. 2002, 2: 281-292. 10.1016\/S1473-3099(02)00263-3.","journal-title":"Lancet Infect Dis"},{"key":"33_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1079-2104(97)90014-7","volume":"83","author":"CM Flaitz","year":"1997","unstructured":"Flaitz CM, Jin YT, Hicks MJ, Nichols CM, Wang YW, Su IJ: Kaposi's sarcoma associated herpesvirus-like DNA sequences (KSHV\/HHV-8) in oral AIDS-Kaposi's sarcoma: a PCR and clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol and Endod. 1997, 83: 259-264. 10.1016\/S1079-2104(97)90014-7.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol and Endod"},{"key":"33_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0889-8588(03)00043-1","volume":"17","author":"JH Von Roenn","year":"2003","unstructured":"Von Roenn JH: Clinical presentations and standard therapy of AIDS-associated Kaposi's sarcoma. Hematol Oncol Clin North Am. 2003, 17: 747-762. 10.1016\/S0889-8588(03)00043-1.","journal-title":"Hematol Oncol Clin North Am"},{"key":"33_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/jac\/dkg086","volume":"51","author":"P Monini","year":"2003","unstructured":"Monini P, Sgadari C, Barillari G, Ensoli B: HIV protease inhibitors: antiretroviral agents with anti-inflammatory, anti-angiogenic and anti-tumour activity. J Antimicrob Chemother. 2003, 51: 207-211. 10.1093\/jac\/dkg086.","journal-title":"J Antimicrob Chemother"},{"key":"33_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1473-3099(02)00288-8","volume":"2","author":"UR Hengge","year":"2002","unstructured":"Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA: Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: Pathogenesis, Castleman's disease and pleural effusion lymphoma. Lancet Infect Dis. 2002, 2: 344-352. 10.1016\/S1473-3099(02)00288-8.","journal-title":"Lancet Infect Dis"},{"key":"33_CR12","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/S0959-8049(01)00121-6","volume":"37","author":"B Ensoli","year":"2001","unstructured":"Ensoli B, Sgadari C, Barillari G, Sirianni MC, Sturzl M, Monini P: Biology of Kaposi's sarcoma. Eur J Cancer. 2001, 37: 1251-69. 10.1016\/S0959-8049(01)00121-6.","journal-title":"Eur J Cancer"},{"key":"33_CR13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0889-8588(03)00042-X","volume":"17","author":"SE Krown","year":"2003","unstructured":"Krown SE: Therapy of AIDS-associated Kaposi's sarcoma: targeting pathogenetic mechanisms. Hematol Oncol Clin North Am. 2003, 17: 763-783. 10.1016\/S0889-8588(03)00042-X.","journal-title":"Hematol Oncol Clin North Am"},{"key":"33_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/jso.20090","volume":"87","author":"RA Schwartz","year":"2004","unstructured":"Schwartz RA: Kaposi's sarcoma: An update. J Surg Oncol. 2004, 87: 146-151. 10.1002\/jso.20090.","journal-title":"J Surg Oncol"},{"key":"33_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0923-1811(01)00087-1","volume":"26","author":"KE Foreman","year":"2001","unstructured":"Foreman KE, Friborg J, Chandran B, Katano H, Sata T, Mercader M, Nabel GJ, Nickoloff BJ: Injection of human herpesvirus-8 in human skin engrafted on SCID induces Kaposi's sarcoma-like lesions. J Dermatol Sci. 2001, 26: 182-193. 10.1016\/S0923-1811(01)00087-1.","journal-title":"J Dermatol Sci"},{"key":"33_CR16","first-page":"314","volume":"61","author":"L Feller","year":"2006","unstructured":"Feller L, Lemmer J, Wood NH, Raubenheimer EJ: Necrotizing gingivitis of Kaposi sarcoma affected gingivae. SADJ. 2006, 61: 314-317.","journal-title":"SADJ"},{"key":"33_CR17","first-page":"1182","volume":"332","author":"PS Moore","year":"1995","unstructured":"Moore PS, Chang Y: Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Eng J Med. 1995, 332: 1182-1185.","journal-title":"N Eng J Med"},{"key":"33_CR18","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(95)90641-X","volume":"345","author":"YQ Huang","year":"1995","unstructured":"Huang YQ, Li JJ, Kaplan MH, Poiesz B, Katabira E, Zhang WC: Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet. 1995, 345: 759-761. 10.1016\/S0140-6736(95)90641-X.","journal-title":"Lancet"},{"key":"33_CR19","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1172\/JCI119492","volume":"99","author":"KE Forman","year":"1997","unstructured":"Forman KE, Bacon PE, Hsi ED, Nickoloff BJ: In situ polymerase chain reaction-based localization studies support role of human herpes virus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma. J Clin Invest. 1997, 99: 2971-2978.","journal-title":"J Clin Invest"},{"key":"33_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0140-6736(95)91619-9","volume":"346","author":"D Whitby","year":"1995","unstructured":"Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C: Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression of Kaposi sarcoma. Lancet. 1995, 346: 799-802. 10.1016\/S0140-6736(95)91619-9.","journal-title":"Lancet"},{"key":"33_CR21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00002030-199602000-00007","volume":"10","author":"PS Moore","year":"1996","unstructured":"Moore PS, Kingsley LA, Holmberg SD, Spira T, Gupta P, Hoover DR: Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS. 1996, 10: 175-180.","journal-title":"AIDS"},{"key":"33_CR22","first-page":"44","volume":"27","author":"A Cattelan","year":"2001","unstructured":"Cattelan A, Calabro ML, Gasperini P, Aversa SM, Zanchetta M, Meneghetti F: Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome. J Natl Cancer Inst Monogr. 2001, 27: 44-49.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"33_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0889-8588(03)00044-3","volume":"17","author":"D Bubman","year":"2003","unstructured":"Bubman D, Cesarman E: Pathogenesis of Kaposi's sarcoma. Hematol Oncol Clin North Am. 2003, 17: 717-745. 10.1016\/S0889-8588(03)00044-3.","journal-title":"Hematol Oncol Clin North Am"},{"key":"33_CR24","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1097\/00002030-200308150-00015","volume":"17","author":"EA Engels","year":"2003","unstructured":"Engels EA, Biggar RJ, Marshall VA, Walters MA, Gamade CJ, Whitby D: Detection and quantification of Kaposi's sarcoma associated herpes virus to predict AIDS-associated Kaposi's sarcoma. AIDS. 2003, 17: 1847-1851. 10.1097\/00002030-200308150-00015.","journal-title":"AIDS"},{"key":"33_CR25","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S0140-6736(96)07560-5","volume":"348","author":"GR Simpson","year":"1996","unstructured":"Simpson GR, Schultz TF, Whitby D, Cook PM, Boshoff C, Rainbow L: Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant caspid protein and latent immunofluorescence antigen. Lancet. 1996, 348: 1133-1138. 10.1016\/S0140-6736(96)07560-5.","journal-title":"Lancet"},{"key":"33_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJM199607253350403","volume":"335","author":"SJ Gao","year":"1996","unstructured":"Gao SJ, Kingsley L, Hoover DR, Spiro TJ, Rinaldo CR, Saah A: Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med. 1996, 335: 233-241. 10.1056\/NEJM199607253350403.","journal-title":"N Engl J Med"},{"key":"33_CR27","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/ajcp\/109.6.778","volume":"109","author":"W Verbeek","year":"1998","unstructured":"Verbeek W, Frankel M, Miles S: Seroprevalence of HHV-8 antibodies in HIV-positive homosexual men without Kaposi's sarcoma and their clinical follow-up. Am J Clin Pathol. 1998, 109: 778-783.","journal-title":"Am J Clin Pathol"},{"key":"33_CR28","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1128\/JCM.36.8.2220-2222.1998","volume":"36","author":"JC Mendez","year":"1998","unstructured":"Mendez JC, Procop GW, Espy MJ, Paya CV, Smith TF: Detection and semiquantitative analysis of human herpesvirus 8 DNA in specimens from patients with Kaposi's sarcoma. J Clin Microbiol. 1998, 36: 2220-2222.","journal-title":"J Clin Microbiol"},{"key":"33_CR29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<500::AID-CNCR3>3.0.CO;2-9","volume":"88","author":"J Iscovich","year":"2000","unstructured":"Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R: Classic Kaposi sarcoma: Epidemiology and risk factors. Cancer. 2000, 88: 500-517. 10.1002\/(SICI)1097-0142(20000201)88:3<500::AID-CNCR3>3.0.CO;2-9.","journal-title":"Cancer"},{"key":"33_CR30","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1086\/426078","volume":"39","author":"E Connick","year":"2004","unstructured":"Connick E, Kane MA, White IE, Ryder J, Campbell TB: Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy. Clin Infect Dis. 2004, 39: 1852-1855. 10.1086\/426078.","journal-title":"Clin Infect Dis"},{"key":"33_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/345084a0","volume":"345","author":"B Ensoli","year":"1990","unstructured":"Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature. 1990, 345: 84-86. 10.1038\/345084a0.","journal-title":"Nature"},{"key":"33_CR32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/371674a0","volume":"371","author":"B Ensoli","year":"1994","unstructured":"Ensoli B, Gendelman R, Markham P, Fiorelli V, Columbini S, Raffeld M: Synergy between basic fibroblast growth factor and the HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature. 1994, 371: 674-680. 10.1038\/371674a0.","journal-title":"Nature"},{"key":"33_CR33","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1200\/JCO.2005.14.597","volume":"23","author":"M Bower","year":"2005","unstructured":"Bower M, Nelson M, Young AM, Thirlwell C, Newsom-Davis T, Mandalia S: Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol. 2005, 23: 5224-5228. 10.1200\/JCO.2005.14.597.","journal-title":"J Clin Oncol"},{"key":"33_CR34","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"FJ Palellla Jr","year":"2003","unstructured":"Palellla FJ, Delaney KM, Marman AC, Loveless MO, Fuhreh J, Salten GA: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 2003, 338: 853-860. 10.1056\/NEJM199803263381301.","journal-title":"N Engl J Med"},{"key":"33_CR35","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.2174\/1568026033451808","volume":"3","author":"S Portsmouth","year":"2003","unstructured":"Portsmouth S, Stebbing J, Gazzard B: Current treatment of HIV infection. Curr Top Med Chem. 2003, 3: 1458-1466. 10.2174\/1568026033451808.","journal-title":"Curr Top Med Chem"},{"key":"33_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1126\/science.277.5322.112","volume":"277","author":"B Autran","year":"1997","unstructured":"Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 1997, 277: 112-116. 10.1126\/science.277.5322.112.","journal-title":"Science"},{"key":"33_CR37","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1086\/340652","volume":"185","author":"EB Quinlivan","year":"2002","unstructured":"Quinlivan EB, Zhang C, Stewart PW, Komoltri C, Davis MG, Wehbie RS: Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. J Infect Dis. 2002, 185: 1736-1744. 10.1086\/340652.","journal-title":"J Infect Dis"},{"key":"33_CR38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00042560-200007010-00013","volume":"24","author":"JL Jones","year":"2000","unstructured":"Jones JL, Hanson DL, Dworkin MS, Jaffe HW: Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. J Acquir Immune Defic Syndr. 2000, 24: 270-274.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"33_CR39","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/00002030-199704000-00017","volume":"11","author":"P Hermans","year":"1997","unstructured":"Hermans P, Lundgren J, Sommereijns B, Katlama C, Chiesi A, Goebel FD: Survival of European patients with Kaposi's sarcoma as AIDS-defining condition during the first decade of AIDS. AIDS in Europe study group. AIDS. 1997, 11: 525-531. 10.1097\/00002030-199704000-00017.","journal-title":"AIDS"},{"key":"33_CR40","doi-asserted-by":"publisher","first-page":"F17","DOI":"10.1097\/00002030-200307250-00001","volume":"17","author":"S Portsmouth","year":"2003","unstructured":"Portsmouth S, Stebbing J, Gill J, Mandalia S, Bower M, Nelson M: A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS. 2003, 17: F17-22. 10.1097\/00002030-200307250-00001.","journal-title":"AIDS"},{"key":"33_CR41","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/00126334-199905010-00056","volume":"21","author":"LP Jacobson","year":"1999","unstructured":"Jacobson LP, Yamashita TE, Detels R, Margolick JB, Chmiel JS, Kingsley LA: Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. J Acquir Immun Defic Syndr. 1999, 21: S34-41.","journal-title":"J Acquir Immun Defic Syndr"},{"key":"33_CR42","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","volume":"92","author":"International Collaboration on HIV and Cancer","year":"2000","unstructured":"International Collaboration on HIV and Cancer: Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Institute. 2000, 92: 1823-1830. 10.1093\/jnci\/92.22.1823.","journal-title":"J Natl Cancer Institute"},{"key":"33_CR43","doi-asserted-by":"publisher","first-page":"F45","DOI":"10.1097\/00002030-199807000-00002","volume":"12","author":"C Lebbe","year":"1998","unstructured":"Lebbe C, Blum L, Pellet C, Blanchard G, Verola O, Morel P: Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS. 1998, 12: F45-49. 10.1097\/00002030-199807000-00002.","journal-title":"AIDS"},{"key":"33_CR44","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0959-8049(99)00161-6","volume":"35","author":"AM Cattelan","year":"1999","unstructured":"Cattelan AM, Calabro ML, Aversa SM, Zanchetta M, Meneghetti F, De Rossi A: Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome. Eur J Cancer. 1999, 35: 1809-1815. 10.1016\/S0959-8049(99)00161-6.","journal-title":"Eur J Cancer"},{"key":"33_CR45","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1378\/chest.117.4.1128","volume":"117","author":"DM Aboulafia","year":"2000","unstructured":"Aboulafia DM: The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma. Chest. 2000, 117: 1128-1145. 10.1378\/chest.117.4.1128.","journal-title":"Chest"},{"key":"33_CR46","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1200\/JCO.2001.19.18.3848","volume":"19","author":"B Holkova","year":"2001","unstructured":"Holkova B, Takeshita K, Cheng DM, Volm M, Wasserheit C, Demopoulos R: Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy. J Clin Oncol. 2001, 19: 3848-3851.","journal-title":"J Clin Oncol"},{"key":"33_CR47","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1046\/j.0022-202x.2001.01465.x","volume":"117","author":"C Pellet","year":"2001","unstructured":"Pellet C, Chevret S, Blum L, Gauville C, Hurault M, Blanchard G: Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy. J Invest Dermatol. 2001, 117: 858-863. 10.1046\/j.0022-202x.2001.01465.x.","journal-title":"J Invest Dermatol"},{"key":"33_CR48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1310\/VQXJ-41X6-GJA2-H6AG","volume":"4","author":"H Leitch","year":"2003","unstructured":"Leitch H, Trudeau M, Routy JP: Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy. HIV Clin Trials. 2003, 4: 107-114. 10.1310\/VQXJ-41X6-GJA2-H6AG.","journal-title":"HIV Clin Trials"},{"key":"33_CR49","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1097\/00002030-199910220-00014","volume":"13","author":"M Bower","year":"1999","unstructured":"Bower M, Fox P, Fife K, Gill J, Nelson M, Gazzard B: Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma. AIDS. 1999, 13: 2105-2111. 10.1097\/00002030-199910220-00014.","journal-title":"AIDS"},{"key":"33_CR50","first-page":"1717","volume":"12","author":"C Martinelli","year":"1998","unstructured":"Martinelli C, Zazzi M, Ambu S, Bartolozzi D, Corsi P, Leoncini F: Complete regression of AIDS-related Kaposi's sarcoma-associated human herpesvirus-8 during therapy with indinavir. AIDS. 1998, 12: 1717-1719.","journal-title":"AIDS"},{"key":"33_CR51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00042560-200206010-00015","volume":"30","author":"VA Paparizos","year":"2002","unstructured":"Paparizos VA, Kyriakis KP, Papastamopoulos V, Hadjivassiliou M, Stavrinaes NG: Response of AIDS-associated Kaposi sarcoma to highly active antiretroviral therapy alone. J Acquir Immune Defic Syndr. 2002, 30: 257-258.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"33_CR52","first-page":"368","volume":"9","author":"J Winceslaus","year":"1998","unstructured":"Winceslaus J: Regression of AIDS-related pleural effusion with HAART: highly active antiretroviral therapy. Int J STD AIDS. 1998, 9: 368-370.","journal-title":"Int J STD AIDS"},{"key":"33_CR53","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrc797","volume":"2","author":"C Boshoff","year":"2002","unstructured":"Boshoff C, Weiss R: AIDS-related malignancies. Nat Rev Cancer. 2002, 2: 373-382. 10.1038\/nrc797.","journal-title":"Nat Rev Cancer"},{"key":"33_CR54","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1002\/cncr.11816","volume":"98","author":"G Nasti","year":"2003","unstructured":"Nasti G, Martellotta F, Beretta M, Menna M, Fasan M, Di Perri G: Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi's sarcoma. Cancer. 2003, 98: 2440-2446. 10.1002\/cncr.11816.","journal-title":"Cancer"},{"key":"33_CR55","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/apc.2005.19.635","volume":"19","author":"RS Leidner","year":"2005","unstructured":"Leidner RS, Aboulafia DM: Recrudescent Kaposi's sarcoma after initiation of HAART: A manifestation of immune reconstitution syndrome. Aids patient care STD. 2005, 19: 635-644. 10.1089\/apc.2005.19.635.","journal-title":"Aids patient care STD"},{"key":"33_CR56","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00005792-200205000-00005","volume":"81","author":"SA Shelburne 3rd","year":"2002","unstructured":"Shelburne SA, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmor RL, Musher DW: Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine. 2002, 81: 213-227. 10.1097\/00005792-200205000-00005.","journal-title":"Medicine"},{"key":"33_CR57","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1097\/00002030-199715000-00022","volume":"11","author":"A Weir","year":"1997","unstructured":"Weir A, Wansbrough-Jones M: Mucosal Kaposi's sarcoma following protease inhibitor therapy in an HIV-infected patient. AIDS. 1997, 11: 1895-1896. 10.1097\/00002030-199715000-00022.","journal-title":"AIDS"},{"key":"33_CR58","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.4065\/78.12.1561","volume":"78","author":"E Rizos","year":"2003","unstructured":"Rizos E, Drosos AA, Ioannidis JP: Isolated intraparotid Kaposi sarcoma in human immunodeficiency virus type 1 infection. Mayo Clin Proc. 2003, 78: 1561-1563.","journal-title":"Mayo Clin Proc"},{"key":"33_CR59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1258\/0956462052932647","volume":"16","author":"HM Crane","year":"2005","unstructured":"Crane HM, Deubner H, Huang JC, Swanson PE, Harrington RD: Fatal Kaposi's sarcoma-associated immune reconstitution following HAART initiation. Int J STD AIDS. 2005, 16: 80-83. 10.1258\/0956462052932647.","journal-title":"Int J STD AIDS"},{"key":"33_CR60","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/carcin\/21.9.1647","volume":"21","author":"SR Mallery","year":"2000","unstructured":"Mallery SR, Pei P, Kang J, Zhu G, Ness GM, Schwendeman SP: Sustained antiogenesis enable in vivo transplantation of mucocutaneous derived AIDS-related Kaposi's sarcoma cells in murine hosts. Carcinogenesis. 2000, 21: 1647-1653. 10.1093\/carcin\/21.9.1647.","journal-title":"Carcinogenesis"},{"key":"33_CR61","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1128\/CMR.15.2.310-326.2002","volume":"15","author":"G Barillari","year":"2002","unstructured":"Barillari G, Ensoli B: Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin Microbiol Rev. 2002, 15: 310-326. 10.1128\/CMR.15.2.310-326.2002.","journal-title":"Clin Microbiol Rev"},{"key":"33_CR62","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1096\/fj.03-1035hyp","volume":"18","author":"A Sodhi","year":"2004","unstructured":"Sodhi A, Montaner S, Gutkind JS: Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?. FASEB J. 2004, 18: 422-427. 10.1096\/fj.03-1035hyp.","journal-title":"FASEB J"},{"key":"33_CR63","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1073\/pnas.0400835101","volume":"101","author":"A Sodhi","year":"2004","unstructured":"Sodhi A, Montaner S, Patel V, Gomez-Roman JJ, Li Y, Sausville EA: Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Proc Natl Acad Sci USA. 2004, 101: 4821-4826. 10.1073\/pnas.0400835101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"33_CR64","first-page":"4873","volume":"60","author":"A Sodhi","year":"2000","unstructured":"Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA: The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1 alpha. Cancer Res. 2000, 60: 4873-4880.","journal-title":"Cancer Res"},{"key":"33_CR65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/0008-5472.CAN-03-2767","volume":"64","author":"PP Naranatt","year":"2004","unstructured":"Naranatt PP, Krishnan HH, Svojanovsky SR, Bloomer C, Mathur S, Chandran B: Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV\/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection. Cancer Res. 2004, 64: 72-84. 10.1158\/0008-5472.CAN-03-2767.","journal-title":"Cancer Res"},{"key":"33_CR66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0065-230X(01)81005-8","volume":"81","author":"B Ensoli","year":"2001","unstructured":"Ensoli B, Sturzl M, Monini P: Reactivation and role of HHV-8 in Kaposi's sarcoma initiation. Adv Cancer Res. 2001, 81: 161-200.","journal-title":"Adv Cancer Res"},{"key":"33_CR67","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1074\/jbc.M306824200","volume":"279","author":"S Buttiglieri","year":"2004","unstructured":"Buttiglieri S, Deregibus MC, Bravo S, Cassoni P, Chiarle R, Bussolati B: Role of Pax 2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells. J Biol Chem. 2004, 279: 4136-4143. 10.1074\/jbc.M306824200.","journal-title":"J Biol Chem"},{"key":"33_CR68","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4049\/jimmunol.167.1.505","volume":"167","author":"M Schwartz","year":"2001","unstructured":"Schwartz M, Murphy PM: Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kB and induces proinflammatory cytokine and chemokine production via a c-terminal signaling determinant. J Immunol. 2001, 167: 505-513.","journal-title":"J Immunol"},{"key":"33_CR69","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1056\/NEJM199704033361403","volume":"336","author":"CS Rabkin","year":"1997","unstructured":"Rabkin CS, Janz S, Lash A, Coleman AE, Musaba E, Liotta L: Monoclonal origin of muilticentric Kaposi's sarcoma lesions. N Engl J Med. 1997, 336: 988-993. 10.1056\/NEJM199704033361403.","journal-title":"N Engl J Med"},{"key":"33_CR70","doi-asserted-by":"publisher","first-page":"8257","DOI":"10.1073\/pnas.95.14.8257","volume":"95","author":"PS Gill","year":"1998","unstructured":"Gill PS, Tsai YC, Rao AP, Spruck CH, Zheng T, Harrington WA: Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci USA. 1998, 95: 8257-8261. 10.1073\/pnas.95.14.8257.","journal-title":"Proc Natl Acad Sci USA"},{"key":"33_CR71","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/carcin\/bgh042","volume":"25","author":"SR Mallery","year":"2004","unstructured":"Mallery SR, Pei P, Landwehr DJ, Clark CM, Bradburn JE, Ness GM: Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi's sarcoma. Carcinogenesis. 2004, 25: 597-603. 10.1093\/carcin\/bgh042.","journal-title":"Carcinogenesis"},{"key":"33_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0092-8674(92)90115-S","volume":"69","author":"RO Hynes","year":"1992","unstructured":"Hynes RO: Integrins: versatility, modulation and signaling in cell adhesion. Cell. 1992, 69: 11-25. 10.1016\/0092-8674(92)90115-S.","journal-title":"Cell"},{"key":"33_CR73","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0021-9150(00)00506-2","volume":"154","author":"G Barillari","year":"2001","unstructured":"Barillari G, Albonici L, Incerpi S, Bogetto L, Pistritto G, Volpi A: Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing \u03b15\u03b21 integrin expression and function. Atherosclerosis. 2001, 154: 377-385. 10.1016\/S0021-9150(00)00506-2.","journal-title":"Atherosclerosis"},{"key":"33_CR74","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1091\/mbc.12.10.2934","volume":"12","author":"E Toschi","year":"2001","unstructured":"Toschi E, Barillari G, Sgadari C, Bacigalupo I, Ceresto A, Carlei D: Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor. Mol Biol Cell. 2001, 12: 2934-2946.","journal-title":"Mol Biol Cell"},{"key":"33_CR75","first-page":"663","volume":"94","author":"G Barillari","year":"1999","unstructured":"Barillari G, Sgadari C, Fiorelli V, Samaniego F, Colombini S, Manzari V: The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the \u03b15\u03b21 and \u03b1v\u03b23 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood. 1999, 94: 663-672.","journal-title":"Blood"},{"key":"33_CR76","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1091\/mbc.E05-08-0717","volume":"17","author":"E Toschi","year":"2006","unstructured":"Toschi E, Bacigalupo I, Strippoli R, Chiozzini C, Cereseto A, Falchi M: HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras\/ERK MAPK signaling pathways. Mol Biol Cell. 2006, 17: 1985-1994. 10.1091\/mbc.E05-08-0717.","journal-title":"Mol Biol Cell"},{"key":"33_CR77","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4049\/jimmunol.168.1.197","volume":"168","author":"E Fanales Belasio","year":"2002","unstructured":"Fanales Belasio E, Moretti S, Nappi F, Barillari G, Micheletti F, Cafaro A: Native HIV-Tat protein targerts monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses. J Immunol. 2002, 168: 197-206.","journal-title":"J Immunol"},{"key":"33_CR78","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/mvre.1997.2056","volume":"55","author":"WJ Lamoreaux","year":"1998","unstructured":"Lamoreaux WJ, Fitzgerald ME, Reiner A, Hasty KA, Charles ST: Vascular endothelial growth factor increases release of gelatinase A and decrease release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res. 1998, 55: 29-42. 10.1006\/mvre.1997.2056.","journal-title":"Microvasc Res"},{"key":"33_CR79","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1073\/pnas.91.8.2890","volume":"91","author":"S Blotnick","year":"1994","unstructured":"Blotnick S, Peoples GE, Freeman MR, Eberlein TJ, Klagsbrun M: T-lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor, and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells. Proc Natl Acad Saci USA. 1994, 91: 2890-2894. 10.1073\/pnas.91.8.2890.","journal-title":"Proc Natl Acad Saci USA"},{"key":"33_CR80","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.4049\/jimmunol.163.4.1929","volume":"15","author":"G Barillari","year":"1999","unstructured":"Barillari G, Sgadari C, Palladino C, Gendelman R, Caputo A, Morris CB: Inflammatory cytokines synergize with HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and \u03b1v\u03b23 integrin. J Immunol. 1999, 15: 1929-1935.","journal-title":"J Immunol"},{"key":"33_CR81","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.4049\/jimmunol.154.7.3582","volume":"154","author":"F Samaniego","year":"1995","unstructured":"Samaniego F, Markham PD, Gallo RC, Ensoli B: Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J Immunol. 1995, 154: 3582-3592.","journal-title":"J Immunol"},{"key":"33_CR82","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S1357-2725(01)00024-3","volume":"33","author":"F Bussolino","year":"2001","unstructured":"Bussolino F, Mitola S, Serini G, Barillari G, Ensoli B: Interactions between endothelial cells and HIV-1. Int J Biochem Cell Biol. 2001, 33: 371-390. 10.1016\/S1357-2725(01)00024-3.","journal-title":"Int J Biochem Cell Biol"},{"key":"33_CR83","first-page":"6020","volume":"9","author":"N Ferrari","year":"2003","unstructured":"Ferrari N, Morini M, Pfeffer U, Minghelli S, Noonan DM, Albini A: Inhibition of Kaposi's sarcoma in vivo by fenretinide. Clin Cancer Res. 2003, 9: 6020-6029.","journal-title":"Clin Cancer Res"},{"key":"33_CR84","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0092-8674(00)81235-0","volume":"85","author":"PC Brooks","year":"1996","unstructured":"Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin \u03b1v\u03b23. Cell. 1996, 85: 683-693. 10.1016\/S0092-8674(00)81235-0.","journal-title":"Cell"},{"key":"33_CR85","first-page":"3411","volume":"53","author":"RE Seftor","year":"1993","unstructured":"Seftor RE, Seftor EA, Stetler-Stevenson WG, Welch DR, Hendrix MJ: The 72 kDa type IV collagenase is modulated via differential expression of \u03b1v\u03b23 and \u03b15\u03b21 integrins during human melanoma cell invasion. Cancer Res. 1993, 53: 3411-3415.","journal-title":"Cancer Res"},{"key":"33_CR86","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/carcin\/19.5.711","volume":"19","author":"DA Wink","year":"1998","unstructured":"Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, Mitchell JB: The multifaceted roles of nitric oxide in cancer. Carcinogenesis. 1998, 19: 711-721. 10.1093\/carcin\/19.5.711.","journal-title":"Carcinogenesis"},{"key":"33_CR87","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/CMR.9.4.532","volume":"9","author":"DR Lucey","year":"1996","unstructured":"Lucey DR, Clerici M, Shearer GM: Type 1 and Type 2 cytokine dysregulation in human infectious, neoplastic and inflammatory diseases. Clin Microbiol Rev. 1996, 9: 532-562.","journal-title":"Clin Microbiol Rev"},{"key":"33_CR88","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1128\/JVI.76.6.2634-2640.2002","volume":"76","author":"J Wilkinson","year":"2002","unstructured":"Wilkinson J, Cope A, Gill J, Bourboulia D, Hayes P, Imami N: Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy. J Virol. 2002, 76: 2634-2640. 10.1128\/JVI.76.6.2634-2640.2002.","journal-title":"J Virol"},{"key":"33_CR89","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0889-8588(03)00047-9","volume":"17","author":"P Robertson","year":"2003","unstructured":"Robertson P, Scadden DT: Immune reconstitution in HIV infection and its relationship to cancer. Hematol Oncol Clin North Am. 2003, 17: 703-716. 10.1016\/S0889-8588(03)00047-9.","journal-title":"Hematol Oncol Clin North Am"},{"key":"33_CR90","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1086\/313809","volume":"30","author":"VCC Cheng","year":"2000","unstructured":"Cheng VCC, Yuen KY, Chan WM, Wong SSY, Ma ESK, Chan RMT: Immunorestitution disease involving the innate and adaptive response. Clin Infec Dis. 2000, 30: 882-892. 10.1086\/313809.","journal-title":"Clin Infec Dis"},{"key":"33_CR91","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1210\/jc.85.11.4254","volume":"85","author":"V Jubault","year":"2000","unstructured":"Jubault V, Penfornis A, Schillo F, Hoen B, Izembart M, Timsit J: Sequential occurrence of thyroid autoantibodies and Grave's disease after immune restoration in severely immunocompromised human immunodeficiency virus-1 infected patients. J Clin Endocrinal Metab. 2000, 85: 4254-4257. 10.1210\/jc.85.11.4254.","journal-title":"J Clin Endocrinal Metab"},{"key":"33_CR92","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","volume":"5","author":"SD Lawn","year":"2005","unstructured":"Lawn SD, Bekker LG, Miller RF: Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis. 2005, 5: 361-373. 10.1016\/S1473-3099(05)70140-7.","journal-title":"Lancet Infect Dis"},{"key":"33_CR93","first-page":"67","volume":"5","author":"SA Shelburne 3rd","year":"2003","unstructured":"Shelburne SA, Hamill RJ: The immune reconstitution inflammatory syndrome. AIDS Rev. 2003, 5: 67-79.","journal-title":"AIDS Rev"},{"key":"33_CR94","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","volume":"19","author":"SA Shelburne","year":"2005","unstructured":"Shelburne SA, Visnegarwala F, Darcourt J, Gravis EA, Giordano TP, White AC: Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005, 19: 399-406. 10.1097\/01.aids.0000161769.06158.8a.","journal-title":"AIDS"},{"key":"33_CR95","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1468-1293.2000.00012.x","volume":"1","author":"MA French","year":"2000","unstructured":"French MA, Lenzo N, John M, Mallai SA, McKinnin EJ, James IR: Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med. 2000, 1: 107-115. 10.1046\/j.1468-1293.2000.00012.x.","journal-title":"HIV Med"},{"key":"33_CR96","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1086\/499356","volume":"42","author":"I Ratnam","year":"2006","unstructured":"Ratnam I, Chiu C, Kandala NB, Easterbrook PJ: Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type-1-infected cohorot. Clin Infect Dis. 2006, 42: 418-427. 10.1086\/499356.","journal-title":"Clin Infect Dis"},{"key":"33_CR97","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1097\/00002030-200209270-00002","volume":"16","author":"H Valdez","year":"2002","unstructured":"Valdez H, Connick E, Smith KY, Leerman MM, Bosch RJ, Kim RS: Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease. AIDS. 2002, 16: 1859-1866. 10.1097\/00002030-200209270-00002.","journal-title":"AIDS"},{"key":"33_CR98","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/25374","volume":"396","author":"DC Douek","year":"1998","unstructured":"Douek DC, McFarland RD, Keiser PH, Cage FA, Massey JM, Haynes BF: Changes in thymic function with age and during treatment of HIV infection. Nature. 1998, 396: 690-695. 10.1038\/25374.","journal-title":"Nature"},{"key":"33_CR99","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1084\/jem.190.5.725","volume":"190","author":"I Zhang","year":"1999","unstructured":"Zhang I, Lewin SR, Markowitz M, Linn HH, Skulski E, Karanicolas R: Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med. 1999, 190: 725-732. 10.1084\/jem.190.5.725.","journal-title":"J Exp Med"},{"key":"33_CR100","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0952-7915(00)00245-4","volume":"13","author":"G Carcelain","year":"2001","unstructured":"Carcelain G, Debre P, Autran B: Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy. Curr Opin Immunol. 2001, 13: 483-488. 10.1016\/S0952-7915(00)00245-4.","journal-title":"Curr Opin Immunol"},{"key":"33_CR101","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1128\/JVI.75.1.234-241.2001","volume":"75","author":"G Carcelain","year":"2001","unstructured":"Carcelain G, Tubiana R, Samri A, Calvez V, Delaugerre C, Augut H: Transient mobilization of human immunodeficiency virus (HIV) \u2013 specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection. J Virol. 2001, 75: 234-241. 10.1128\/JVI.75.1.234-241.2001.","journal-title":"J Virol"},{"key":"33_CR102","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nm0298-208","volume":"4","author":"NG Pakker","year":"1998","unstructured":"Pakker NG, Notermans DW, be Boer RJ, Roos MT, de Wolf F, Hill A: Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med. 1998, 4: 208-214. 10.1038\/nm0298-208.","journal-title":"Nat Med"},{"key":"33_CR103","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1172\/JCI5863","volume":"103","author":"RP Bucy","year":"1999","unstructured":"Bucy RP, Hockett RD, Derdeyn CA, Saag MS, Squires K, Sillers M: Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest. 1999, 103: 1391-1398. 10.1172\/JCI5863.","journal-title":"J Clin Invest"},{"key":"33_CR104","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/315171","volume":"181","author":"E Connick","year":"2000","unstructured":"Connick E, Lederman MM, Kotzin BL, Spritzler J, Kuritzkes DR, St Clair M: Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. J Infec Dis. 2000, 181: 358-363. 10.1086\/315171.","journal-title":"J Infec Dis"},{"key":"33_CR105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1086\/515591","volume":"178","author":"MM Lederman","year":"1998","unstructured":"Lederman MM, Connick E, Landay A, Kuritzkes DR, Spritzler J, St Clair M: Immunologic responses associated with 12 weeks combination antiretroviral therapy consisting of zidovudine, lamivudine and ritonavir: results of AIDS Clinical Trials Group Protocol 315. J Infect Dis. 1998, 178: 70-79.","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"33_CR106","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/00002030-200102002-00003","volume":"15","author":"MM Lederman","year":"2001","unstructured":"Lederman MM: Immune restoration and CD4+ T-cell function with antiretroviral therapies. AIDS. 2001, 15 (Suppl 2): S11-15. 10.1097\/00002030-200102002-00003.","journal-title":"AIDS"},{"key":"33_CR107","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1468-1293.2005.00277.x","volume":"6","author":"DJ Jevtovic","year":"2005","unstructured":"Jevtovic DJ, Salemovic D, Pesic I, Zerjav S, Djurkovic-Djakovic O: The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy. HIV Med. 2005, 6: 140-143. 10.1111\/j.1468-1293.2005.00277.x.","journal-title":"HIV Med"},{"key":"33_CR108","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1086\/503903","volume":"42","author":"J Robertson","year":"2006","unstructured":"Robertson J, Meier M, Wall J, Ying J, Fichtenbaum CJ: Immune reconstitution syndrome in HIV: Validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis. 2006, 42: 1639-1646. 10.1086\/503903.","journal-title":"Clin Infect Dis"},{"key":"33_CR109","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1086\/425742","volume":"39","author":"G Breton","year":"2004","unstructured":"Breton G, Duval X, Estellat C, Paoletti X, Bonnet D, Mvondo D: Determinants of immune reconstitution inflammatory syndrome in HIV type-1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis. 2004, 39: 1709-1712. 10.1086\/425742.","journal-title":"Clin Infect Dis"},{"key":"33_CR110","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1086\/515019","volume":"27","author":"E Martinez","year":"1998","unstructured":"Martinez E, Gatell J, Moran Y, Aznar E, Buira E, Guelar A: High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infect Dis. 1998, 27: 1510-1513. 10.1086\/515019.","journal-title":"Clin Infect Dis"},{"key":"33_CR111","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0002-9343(01)00703-3","volume":"110","author":"P Domingo","year":"2001","unstructured":"Domingo P, Torres OH, Ris J, Vazquez G: Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection. Am J Med. 2001, 110: 605-609. 10.1016\/S0002-9343(01)00703-3.","journal-title":"Am J Med"},{"key":"33_CR112","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/00002030-199902040-00005","volume":"13","author":"NA Foudraine","year":"1999","unstructured":"Foudraine NA, Hovenkamp E, Natermans DW, Meenhorst PL, Klein MR, Lange JMA: Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infeted patients. AIDS. 1999, 13: 177-184. 10.1097\/00002030-199902040-00005.","journal-title":"AIDS"},{"key":"33_CR113","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/00002030-199211000-00009","volume":"6","author":"MAH French","year":"1992","unstructured":"French MAH, Malal SA, Dawkins RL: Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS. 1992, 6: 1293-1297. 10.1097\/00002030-199211000-00009.","journal-title":"AIDS"},{"key":"33_CR114","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1128\/JVI.73.7.6136-6140.1999","volume":"73","author":"M Osman","year":"1999","unstructured":"Osman M, Kubo T, Gill J, Neipel F, Becker M, Smith G: Identification of human herpesvirus 8-specific cytotoxic T-cell responses. J Virol. 1999, 73: 6136-6140.","journal-title":"J Virol"},{"key":"33_CR115","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1086\/383034","volume":"38","author":"H Hirsh","year":"2004","unstructured":"Hirsh H, Kaufmann G, Sendi P, Battegay M: Immune reconstitution in HIV-infected patients. Clin Infect Dis. 2004, 38: 1159-1166. 10.1086\/383034.","journal-title":"Clin Infect Dis"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-3-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1750-9378-3-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-3-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:19:24Z","timestamp":1684196364000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/1750-9378-3-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,21]]},"references-count":115,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["33"],"URL":"https:\/\/doi.org\/10.1186\/1750-9378-3-1","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,21]]},"article-number":"1"}}